Related references
Note: Only part of the references are listed.Adipose-tissue plasticity in health and disease
Alexander Sakers et al.
CELL (2022)
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease
Ajay Duseja et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2022)
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an inter-national registry study
Eunice Xiang-Xuan Tan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Ramy Younes et al.
GUT (2022)
NAFLD in lean individuals: not a benign disease
Sven Francque et al.
GUT (2022)
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
Alessandro Mantovani et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
Vittoria Zambon Azevedo et al.
FRONTIERS IN NUTRITION (2022)
NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver
Arka De et al.
JOURNAL OF HEPATOLOGY (2022)
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
Xinxing Tantai et al.
JOURNAL OF HEPATOLOGY (2022)
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review
Michelle T. Long et al.
GASTROENTEROLOGY (2022)
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases
Ethan M. Weinberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models
Maxime Nachit et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M. Francque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2021)
Muscle fat content is strongly associated with NASH: a longitudinal study in patients with morbid obesity
Maxime Nachit et al.
JOURNAL OF HEPATOLOGY (2021)
Non-alcoholic fatty liver disease
Elizabeth E. Powell et al.
LANCET (2021)
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Mohammad Shafi Kuchay et al.
BIOMEDICINES (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
Amalia Gastaldelli et al.
LIVER INTERNATIONAL (2021)
Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
Jennifer Linge et al.
JHEP REPORTS (2021)
Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis
Changzhou Cai et al.
HEPATOLOGY INTERNATIONAL (2020)
Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease
Charmaine Fu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Fei Chen et al.
HEPATOLOGY (2020)
Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox
Sanjaya K. Satapathy et al.
LIVER TRANSPLANTATION (2020)
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Robert Ross et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
SGLT2 Inhibitors in Liver Patients
John Chen Hsiang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016
B. Zou et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan
Takashi Shida et al.
HEPATOLOGY RESEARCH (2020)
Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis
Feng-Bin Lu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2020)
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
Giljae Lee et al.
NATURE COMMUNICATIONS (2020)
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis
Steven Young et al.
HEPATOLOGY COMMUNICATIONS (2020)
A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity
Kazuhiro Kashiwagi et al.
CLINICAL NUTRITION ESPEN (2020)
Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients
Shunji Hirose et al.
PLOS ONE (2020)
Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
Yeojun Yun et al.
PLOS ONE (2019)
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
Ian J. Neeland et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
GUT (2019)
Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign
Maki Tobari et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi et al.
JHEP REPORTS (2019)
Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis
Vincent Wai-Sun Wong et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
Rui Yu et al.
BMC GASTROENTEROLOGY (2018)
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise
Vincent Wai-Sun Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study
S. M. B. Duarte et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2018)
Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study
Joo Hee Kwak et al.
CLINICAL NUTRITION (2018)
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2018)
Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease
S. Sookoian et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Risk for Development of Severe Liver Disease in Lean Patients With Nonalcoholic Fatty Liver Disease: A Long-Term Follow-Up Study
Hannes Hagstrom et al.
HEPATOLOGY COMMUNICATIONS (2018)
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
Alexandra Feldman et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Histological Severity and Clinical Outcomes of Nonalcoholic Fatty Liver Disease in Nonobese Patients
Jonathan Chung-Fai Leung et al.
HEPATOLOGY (2017)
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Charlie C. Park et al.
GASTROENTEROLOGY (2017)
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity
Anna Ludovica Fracanzani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis
Suzanne E. Mahady et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients
S. Sookoian et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Donghee Kim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
Donghee Kim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Sarcopenia Is Associated With Significant Liver Fibrosis Independently of Obesity and Insulin Resistance in Nonalcoholic Fatty Liver Disease: Nationwide Surveys (KNHANES 2008-2011)
Yong-ho Lee et al.
HEPATOLOGY (2016)
Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors
Yasushi Honda et al.
HEPATOLOGY RESEARCH (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
Jeremy Lok Wei et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Normal weight individuals who develop Type 2 diabetes: the personal fat threshold
Roy Taylor et al.
CLINICAL SCIENCE (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis
B. Wang et al.
HORMONE AND METABOLIC RESEARCH (2015)
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2015)
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Su Jong Yu et al.
MEDICINE (2015)
Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease
Goh Eun Chung et al.
MEDICINE (2015)
Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?
Shivaram Prasad Singh et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels
Umit Akyuz et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Imaging Body Fat Techniques and Cardiometabolic Implications
H. Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh
Shahinul Alam et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2014)
Are Metabolically Healthy Overweight and Obesity Benign Conditions? A Systematic Review and Meta-analysis
Caroline K. Kramer et al.
ANNALS OF INTERNAL MEDICINE (2013)
The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease
Aikaterini Margariti et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2013)
The relationship between BMI and percent body fat, measured by bioelectrical impedance, in a large adult sample is curvilinear and influenced by age and sex
S. Meeuwsen et al.
CLINICAL NUTRITION (2010)
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
Kenichiro Yasutake et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Soft drink consumption linked with fatty liver in the absence of traditional risk factors
Nimer Assy et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
BMI-related errors in the measurement of obesity
K. J. Rothman
INTERNATIONAL JOURNAL OF OBESITY (2008)
Visceral adipose tissue area is an independent risk factor for hepatic steatosis
Bum J. Park et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
C Barba et al.
LANCET (2004)
Share Paper
